Serviceitis

What is cervicitis and how does cervical inflammation develop?

Cervicitis is an inflammatory disease of the cervix (cervix uteri), the tissue that connects the uterus with the vagina. This inflammation primarily affects the cervical mucosa and can be either acute or chronic. In many cases, it is asymptomatic and therefore initially goes unnoticed. Cervicitis becomes particularly problematic when it ascends and affects neighboring structures such as the uterine lining or fallopian tubes – a development known as Pelvic Inflammatory Disease (PID) summarized.

The development of cervicitis is closely related to the balance of the vaginal flora and mechanical or infectious influences. A disturbed vaginal flora, mucosal lesions, or frequently changing sexual partners can significantly increase the risk. In particular, the penetration of pathogens from the vagina into the cervix promotes the inflammatory process.

What symptoms occur with cervicitis?

The symptomatology of cervicitis can vary greatly. In the acute form, discharge, intermenstrual bleeding, or pain during sexual intercourse often occur. Chronic cervicitis, on the other hand, often runs silently and is frequently discovered incidentally during gynecological check-ups.

Typical complaints include:

• Excessive or unusual vaginal discharge (often purulent, yellowish, or greenish)
• Contact bleeding, especially after sexual intercourse
• Dysuria (painful urination)
• Lower abdominal discomfort or a feeling of pressure in the pelvis
• Itching and burning in the intimate area
• Pain during intercourse (dyspareunia)

What causes can cervicitis have – infectious and non-infectious?

The causes can basically be divided into two main groups: infectious and non-infectious triggers. In most cases, cervicitis is caused by pathogens – especially frequently by sexually transmitted infections. In addition, there are also chemical, mechanical, or hormonally induced irritants.

How is cervicitis diagnosed by the gynecologist?

The diagnosis of cervicitis usually begins with a detailed medical history interview, in which symptoms such as discharge, intermenstrual bleeding, or pain during sexual intercourse are asked about. Many patients report vaginal changes or notice symptoms only during a routine gynecological examination.

In the next step, the gynecologist performs a physical examination. Using a speculum, the cervix is made visible. Typical signs of cervicitis are reddened, swollen mucous membranes, purulent discharge from the cervical opening, or increased bleeding tendency of the cervix upon touch.

To confirm the diagnosis, a smear is taken from the cervix. The collected secretion is microbiologically examined – either by cultural detection methods or modern molecular biological methods such as the PCR test. This way, pathogens like Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium or Trichomonas vaginalis clearly identified.

If herpes infection or HPV-related changes are suspected, an additional cytological smear (Pap test) and, if necessary, a colposcopy are performed. If an ascending infection is suspected, a vaginal sonography may also be necessary.

• Gynecological palpation and visual examination
• Cervical smear for microbial diagnostics (including PCR in case of suspected STD)
• Pap test to assess cellular changes
• Colposcopy for abnormal findings
• Ultrasound examination in case of suspected complications

What role do sexually transmitted diseases play in the development of cervicitis?

Sexually transmitted infections (STIs) are among the most common causes of infectious cervicitis. Especially young, sexually active women are affected. Transmission usually occurs through unprotected sexual intercourse with an infected partner. A characteristic of STI-related cervicitis is that the pathogens ascend from the vagina through the cervix and trigger an inflammatory reaction there. If the infection is not treated, it can spread to the upper genital organs and lead to serious complications such as endometritis or salpingitis.

The most important sexually transmitted pathogens that can cause cervicitis include:

• Chlamydia trachomatis: The most common cause. Infections often proceed asymptomatically but can lead to scarring of the fallopian tubes and thus infertility.
• Neisseria gonorrhoeae: Causes gonorrhea and leads to purulent discharge and bleeding tendency at the cervix.
• Mycoplasma genitalium: An increasingly important but difficult-to-detect cause of chronic cervicitis.
• Trichomonas vaginalis: A protozoan that is mainly considered in cases of increased, frothy discharge.
• Herpes simplex virus (HSV-2): Causes painful blisters and can lead to recurrent inflammation of the cervix.

The infection often goes unnoticed because many pathogens do not cause immediate or specific symptoms. It is all the more important to perform a cervical swab for STIs if abnormalities such as discharge, bleeding, or pain during sexual intercourse occur. Even asymptomatic patients should be regularly tested for chlamydia as part of preventive care – especially if they wish to have children or have frequently changing sexual partners.

How is cervicitis treated – antibiotics, antifungals, or antivirals?

The treatment of cervicitis depends on the underlying cause and the identified pathogen. In most cases, it is an infectious inflammation that requires targeted anti-infective therapy. The choice of medication – antibiotic, antifungal, or antiviral – is made according to the microbial spectrum of pathogens. In uncomplicated cases, empirical treatment can already be initiated, especially if typical symptoms are present or an STI is suspected.

In many cases – such as with chlamydia or gonorrhea – combined antibiotic therapy is started immediately, even before lab results are complete. The rapid intervention aims to prevent complications like ascending infections or chronic inflammation.

Example of a standard treatment for STI-associated cervicitis:

• Chlamydia: Single dose of 1 g azithromycin orally or doxycycline twice daily for 7 days
• Gonorrhea: Single intramuscular injection of 500 mg ceftriaxone plus 1 g azithromycin orally

If a CandidaIf an infection is detected, therapy is carried out with antifungals – either locally (e.g., as suppositories) or systemically. Herpes infections require antiviral medications, which control but do not eliminate the infection.

After targeted anti-infective therapy, the vaginal mucosa can be affected by inflammation, medication, or the infection itself. Targeted mucosal care and regeneration with CANNEFF® vaginal suppositories is recommended here.

CANNEFF® vaginal suppositories: have anti-inflammatory and pain-relieving effects, support mucosal regeneration, bind moisture, and stabilize the vaginal environment. The suppositories can be used alongside acute treatment or for persistent irritation – especially in cases of recurrent or chronic cervicitis, in women with sensitive mucosa, or during menopause. CANNEFF® thus helps relieve residual symptoms and can promote the return to a normal vaginal flora.

What complications can occur with untreated cervicitis?

If cervicitis is not diagnosed and treated in time, it can spread beyond the cervix to adjacent organs of the internal genital tract. The result can be severe inflammatory diseases that not only cause acute symptoms but also increase the risk of long-term damage – such as infertility, chronic pelvic pain, or ectopic pregnancies.

Particularly dangerous are ascending infections, where pathogens travel from the cervix into the uterine cavity (endometrium), the fallopian tubes, and the ovaries. This progression is summarized under the term Pelvic Inflammatory Disease (PID) and is associated with an increased risk of irreversible tissue damage.

Persistent infections with certain viruses, especially Human Papillomavirus (HPV), can also lead to the development of dysplasias or cervical cancers in the long term – particularly in women with weakened immune systems.

When should you see a doctor if cervicitis is suspected?

Early medical consultation is crucial if cervicitis is suspected to prevent the spread of inflammation and avoid complications. Even though the disease often occurs without symptoms, there are typical complaints for which medical evaluation is strongly recommended.

The following signs should always be examined gynecologically:

• Unusual vaginal discharge – especially if it is yellowish, greenish, purulent, foamy, or unpleasant-smelling
• Intermenstrual bleeding – especially bleeding outside of menstruation or after sexual intercourse
• Pain during intercourse (dyspareunia)
• Burning or pain when urinating (dysuria)
• Itching, redness, or irritation in the intimate area
• Lower abdominal pain or a feeling of pressure in the pelvis
• Fever or general malaise indicating an ascending infection

A doctor's appointment should also take place without symptoms if:

• A sexual partner has tested positive for chlamydia, gonorrhea, or other STIs
• There have been risk contacts (e.g., unprotected sex with multiple partners)
• The patient is pregnant – untreated cervicitis can increase the risk of premature birth
• A HPV infection or abnormal Pap smear results are known from medical history

Women especially in or after menopause, who tend to develop atrophy of the vaginal and cervical mucosa due to hormonal changes, should seek medical advice even with mild irritation symptoms. The tendency for inflammation is increased during this phase of life, even if no infection is present.

In the early stage, cervicitis can usually be treated easily – depending on the cause with antibiotics, antifungals, or antivirals. To relieve local irritation, especially in non-infectious or post-infectious cervicitis, CANNEFF® vaginal suppositories can be used as a supportive treatment. Their ingredients – CBD and hyaluronic acid – have a soothing, anti-inflammatory effect and promote mucous membrane regeneration without disturbing the vaginal microbiome. CANNEFF® is particularly suitable for sensitive or weakened vaginal mucosa, for example during hormonal changes.

How can cervicitis be prevented?

Prevention of cervicitis is based on two central strategies: protection against sexually transmitted infections (STIs) and avoidance of local irritants that can weaken or inflame the cervical mucosa. Since many cervicitis cases are asymptomatic, regular gynecological check-ups also play a crucial role.

The most important preventive measures include:

• Use of condoms during every sexual intercourse—they provide protection against STIs like chlamydia, gonorrhea, herpes, or HPV.
• Reduction of risk contacts, e.g., by avoiding frequent partner changes or sexual contacts with partners showing symptoms.
• Regular gynecological examinations, even without acute symptoms—especially for young women and women wishing to conceive.
• Treatment of vaginal infections, such as bacterial vaginosis or yeast infections, before they can spread to the cervix.
• Avoidance of aggressive intimate care products, perfumed soaps, or vaginal douches that disrupt the natural vaginal flora.
• Avoidance of excessive mechanical irritation, e.g., from diaphragms, long-lasting tampons, or improperly placed contraceptives.
• Vaccination against HPV, especially in adolescence, can significantly reduce the risk of HPV-related cervicitis and later dysplasias.

Is cervicitis more common during menopause and what special features apply then?

Cervicitis occurs overall less frequently during menopause than in younger, sexually active women, yet it plays a special role in this life phase—mainly due to hormonal changes that make the vaginal and cervical mucosa more sensitive and prone to inflammation. The declining estrogen level leads to mucosal atrophy (tissue loss), reduced blood flow, and a decrease in the protective lactobacillus flora. This promotes irritation, microtears, and a disturbed barrier function—even without infection.

In postmenopause, cervicitis can also be non-infectious: caused by dryness, mechanical irritation (e.g., during gynecological exams or sexual intercourse), chemical irritants in intimate care products, or local allergies. These forms often progress subtly but manifest as burning, discharge, or bleeding and should be evaluated gynecologically.

Special features of cervicitis during menopause:

• Increased mucosal sensitivity due to estrogen deficiency
• Reduced infection protection due to disturbed vaginal environment
• Often non-infectious triggers (mechanical, chemical, hormonal)
• Increased contact bleeding with vaginal atrophy
• Often chronic course with diffuse irritation conditions

During menopause, the vaginal mucosa undergoes hormonal changes that lead to atrophy, dryness, and increased susceptibility to inflammatory processes such as cervicitis. The natural protective barrier of the cervix is weakened by estrogen deficiency, increasing the risk of micro-injuries, irritation, and infections – even from non-sexual triggers.

CANNEFF® VAG SUP suppositories, developed for the treatment of typical menopausal complaints, are therefore also excellently suited for supportive care in cervicitis during postmenopause. The synergistic combination of hyaluronic acid and CBD works specifically:

• CANNEFF® improves the moisture and regeneration of the atrophic cervical and vaginal mucosa, supporting faster healing of inflamed areas.
  
• CANNEFF® reduces local inflammatory reactions, relieves pain, and soothes irritated tissue – a particularly valuable effect in chronic or irritation-induced cervicitis.

Clinical studies also show that the regular use of CANNEFF® suppositories not only relieves vaginal symptoms but also positively affects systemic menopausal complaints such as sleep disorders, hot flashes, and nervousness. Women with cervicitis thus benefit doubly: from the local healing effect and an improved overall quality of life. The hormone-free and well-tolerated formula makes CANNEFF® the ideal option for women who want or need to avoid hormone replacement therapy.